Aravindhan Veerapandiyan, MD

Articles by Aravindhan Veerapandiyan, MD

Early Biomarker Signals From SGT-003 Highlight Ongoing Progress in Duchenne Gene Therapy

ByMarco Meglio,Aravindhan Veerapandiyan, MD

April 17th 2026

Investigators discuss interim phase 1/2 INSPIRE DUCHENNE data and the emerging biomarker and safety profile of SGT-003 in Duchenne muscular dystrophy.

Aravindhan Veerapandiyan, MD

Articles by Aravindhan Veerapandiyan, MD

Early Biomarker Signals From SGT-003 Highlight Ongoing Progress in Duchenne Gene Therapy

Latest Updated Articles